Related Experiment Video
Updated: Jun 22, 2026
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
Published on: October 23, 2019
Protein kinase inhibitor-induced endothelial cell cytotoxicity and its prediction based on calculated molecular
Eszter Herczenik1, Zoltán Varga, Dániel Eros
1Research Group of Inflammation Biology and Immunogenomics, Hungarian Academy of Sciences-Semmelweis University, Budapest, Hungary.
Abstract:
Protein kinase inhibitors (PKIs) as potent signal transduction therapeutic compounds represent a very rapidly expanding group of anticancer drugs. These agents may be toxic for endothelial cells, however, very few experimental data exist on the cytotoxicity of PKIs. The aim of this study was to set up an appropriate test system for endothelial cells and to assess the structure-related cytotoxic effects of a selected library of PKIs. The inhibitor library contains several lead molecules with different basic structures and a set of modified derivatives of the lead compounds. The toxicity of PKIs did not correlate directly with the structural features of the molecules. However, we successfully built up a model based on 15 calculated molecular descriptors, which is capable of predicting cytotoxicity with acceptable probability. Our results show that the cytotoxic effects of PKIs should be taken into account for optimal drug development to overcome endothelial cell-related side effects.
Insights
Protein kinase inhibitors (PKIs) are promising anticancer drugs but can harm endothelial cells. This study developed a predictive model for PKI cytotoxicity, aiding safer drug development.
Area of Science:
- Pharmacology
- Oncology
- Cell Biology
Background:
- Protein kinase inhibitors (PKIs) are a growing class of anticancer therapeutics targeting signal transduction pathways.
- Limited data exist on the cytotoxicity of PKIs, particularly concerning their effects on endothelial cells.
- Endothelial cell toxicity is a significant concern for drug development and patient safety.
Purpose of the Study:
- To establish a reliable test system for evaluating endothelial cell cytotoxicity induced by PKIs.
- To investigate the relationship between chemical structure and cytotoxic effects within a library of PKIs.
- To develop a predictive model for PKI-induced cytotoxicity based on molecular descriptors.
Main Methods:
- Development of a specialized in vitro test system for assessing endothelial cell viability.
- Synthesis and screening of a diverse library of PKIs, including lead compounds and their derivatives.
- Quantitative Structure-Activity Relationship (QSAR) analysis using 15 calculated molecular descriptors to build a predictive model.
Main Results:
- Cytotoxicity of PKIs did not show a direct correlation with their structural features alone.
- A predictive model was successfully developed, capable of forecasting PKI cytotoxicity with reasonable accuracy.
- The model utilizes 15 distinct molecular descriptors to predict potential toxicity.
Conclusions:
- Endothelial cell toxicity is a critical factor to consider during the development of protein kinase inhibitors.
- The developed predictive model offers a valuable tool for early-stage assessment of PKI safety.
- Incorporating cytotoxicity assessments early can mitigate endothelial cell-related side effects in anticancer drug development.
